Endurance exercise training beneficially modifies gut microbiota composition.
A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans, according to research led by UCSF Benioff Children's Hospitals and Children's National Health System.
Young women previously treated for cancer with chemotherapy or radiation therapy with a prior history of cardiotoxicity are more likely to develop clinical congestive heart failure (CHF) during and after pregnancy, according to a study published today in the Journal of the American College of Cardiology.
A research team has discovered that abnormal vision in childhood can affect the development of higher-level brain areas responsible for things such as attention.
A new 'metal-coordinated' drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly 10 million Americans, and many more patients worldwide, according to results of a study published in the journal Thyroid this month.
Three prominent medical societies today issued a new clinical guideline for physicians treating men with early-stage prostate cancer using external beam radiation therapy (EBRT). Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer. Developed by a panel of experts from ASTRO, ASCO and AUA, the new guideline recommends offering patients a treatment option known as hypofractionated radiation therapy as an alternative to longer, conventional courses of radiation.
First study focusing on this population addresses important research gap.
Researchers say they have discovered a gene mutation that slows the metabolism of sugar in the gut, giving people who have the mutation a distinct advantage over those who do not. Those with the mutation have a lower risk of diabetes, obesity, heart failure, and even death. The researchers say their finding could provide the basis for drug therapies that could mimic the workings of this gene mutation, offering a potential benefit for the millions of people who suffer with diabetes, heart disease, and obesity.
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA mutations in their tumours. This achievement, to be reported at the ESMO 2018 Congress in Munich, shows that cutting-edge precision medicine is spreading from highly specialist cancer units to other healthcare facilities so more patients can benefit, wherever they are treated.
Researchers at University of California San Diego School of Medicine, with collaborators across the country, report that people who participate in dementia prevention trials are primarily motivated by altruism and pleased to help.